Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in Chronic Obstructive Pulmonary Disease? Results from Post Hoc Subgroup Analyses

BACKGROUND: Chronic obstructive pulmonary disease (COPD) patients with blood eosinophil (EOS) count ≥2 % benefit from exacerbation reductions with inhaled corticosteroids (ICSs). We conducted post hoc analyses to determine if EOS count ≥2 % is a marker for greater responsiveness to the bronchodilato...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Ahmar, Barnes, Neil C., Brooks, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579251/
https://www.ncbi.nlm.nih.gov/pubmed/26329916
http://dx.doi.org/10.1007/s40261-015-0322-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579251/
https://www.ncbi.nlm.nih.gov/pubmed/26329916
http://dx.doi.org/10.1007/s40261-015-0322-6

Ejemplares similares